相关实验视频
Updated: Sep 18, 2025

08:17
Reducing State Anxiety Using Working Memory Maintenance
Published on: July 19, 2017
7.6K
心理干预以减少心律失常患者的痛苦
Josefin Särnholm1,2, Allison E Gaffey3,4, Meghan Reading Turchio5
1Department of Clinical Neuroscience, Division of Psychology, Karolinska Institutet, Nobels väg 9, Stockholm, 171 65, Sweden. josefin.sarnholm@ki.se.
Current cardiology reports
|June 25, 2025
概括
认知行为疗法 (CBT) 有效地减少了心理困扰,并改善了心律失常患者的生活质量. 将CBT整合到常规护理中可以提高这些患者的临床结果.
科学领域:
- 心脏病学 心脏病学
- 心理学 心理学 心理学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心脏节律失常,如心房动 (AF) 和心室节律失常 (VA),与心理困扰有关,包括焦虑和抑郁,影响患者的生活质量 (QoL).
- 心理健康显著影响患有心律失常的个体的临床轨迹和预后.
- 目前的心律失常治疗往往缺乏足够的整合心理健康支持.
研究的目的:
- 审查心理干预的应用,重点是认知行为疗法 (CBT),用于管理心律失常患者的心理健康.
- 探索将这些干预措施整合到标准心律失常治疗途径中的策略.
主要方法:
- 针对心律失常患者心理干预的集中文献综述.
- 检查认知行为疗法 (CBT) 的有效性和实施策略.
主要成果:
- 认知认知疗法在缓解焦虑,抑郁,心脏恐惧和回避行为方面表现出有效性,并改善了心律失常患者的QoL.
- 需要进一步的研究来验证CBT在现实世界医疗保健系统中的有效性.
- 跨学科的合作对于将心理健康纳入心律失常管理至关重要.
结论:
- 将CBT整合到心律失常治疗中,有可能改善患者的临床结果.
- 加强心理支持对于综合性心律失常患者管理至关重要.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
114
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
114
Dysrhythmias VII: Nursing Management of Dysrhythmias
112
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
112
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Disturbances in Heart Rhythm
1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
Dysrhythmias V: Evaluating Dysrhythmias
123
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
123
Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39

